Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Acne Vulgaris Treatment Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 CB-0601
  • 1.3.3 CJM-112
  • 1.3.4 CLS-007
  • 1.3.5 Dapsone
  • 1.3.6 DFD-10
  • 1.3.7 DLX-2323
  • 1.3.8 Others
• 1.4 Market Segment by Application
  • 1.4.1 Global Acne Vulgaris Treatment Market Share by Application (2019-2025)
  • 1.4.2 Clinic
  • 1.4.3 Hospital
  • 1.4.4 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Acne Vulgaris Treatment Market Size
  • 2.1.1 Global Acne Vulgaris Treatment Revenue 2014-2025
  • 2.1.2 Global Acne Vulgaris Treatment Sales 2014-2025
• 2.2 Acne Vulgaris Treatment Growth Rate by Regions
  • 2.2.1 Global Acne Vulgaris Treatment Sales by Regions 2014-2019
  • 2.2.2 Global Acne Vulgaris Treatment Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Acne Vulgaris Treatment Sales by Manufacturers
  • 3.1.1 Acne Vulgaris Treatment Sales by Manufacturers 2014-2019
  • 3.1.2 Acne Vulgaris Treatment Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Acne Vulgaris Treatment Revenue by Manufacturers (2014-2019)
  • 3.2.2 Acne Vulgaris Treatment Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Acne Vulgaris Treatment Market Concentration Ratio (CR5 and HHI)
• 3.3 Acne Vulgaris Treatment Price by Manufacturers
• 3.4 Key Manufacturers Acne Vulgaris Treatment Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Acne Vulgaris Treatment Market
• 3.6 Key Manufacturers Acne Vulgaris Treatment Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 CB-0601 Sales and Revenue (2014-2019)
  • 4.1.2 CJM-112 Sales and Revenue (2014-2019)
  • 4.1.3 CLS-007 Sales and Revenue (2014-2019)
  • 4.1.4 Dapsone Sales and Revenue (2014-2019)
  • 4.1.5 DFD-10 Sales and Revenue (2014-2019)
  • 4.1.6 DLX-2323 Sales and Revenue (2014-2019)
  • 4.1.7 Others Sales and Revenue (2014-2019)
• 4.2 Global Acne Vulgaris Treatment Sales Market Share by Type
• 4.3 Global Acne Vulgaris Treatment Revenue Market Share by Type
• 4.4 Acne Vulgaris Treatment Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Acne Vulgaris Treatment Sales by Application

6 United States

• 6.1 United States Acne Vulgaris Treatment Breakdown Data by Company
• 6.2 United States Acne Vulgaris Treatment Breakdown Data by Type
• 6.3 United States Acne Vulgaris Treatment Breakdown Data by Application

7 European Union

• 7.1 European Union Acne Vulgaris Treatment Breakdown Data by Company
• 7.2 European Union Acne Vulgaris Treatment Breakdown Data by Type
• 7.3 European Union Acne Vulgaris Treatment Breakdown Data by Application

8 China

• 8.1 China Acne Vulgaris Treatment Breakdown Data by Company
• 8.2 China Acne Vulgaris Treatment Breakdown Data by Type
• 8.3 China Acne Vulgaris Treatment Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Acne Vulgaris Treatment Breakdown Data by Company
• 9.2 Rest of World Acne Vulgaris Treatment Breakdown Data by Type
• 9.3 Rest of World Acne Vulgaris Treatment Breakdown Data by Application
• 9.4 Rest of World Acne Vulgaris Treatment Breakdown Data by Countries
  • 9.4.1 Rest of World Acne Vulgaris Treatment Sales by Countries
  • 9.4.2 Rest of World Acne Vulgaris Treatment Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Common Pharma Inc
  • 10.1.1 Common Pharma Inc Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Acne Vulgaris Treatment
  • 10.1.4 Acne Vulgaris Treatment Product Introduction
  • 10.1.5 Common Pharma Inc Recent Development
• 10.2 Cutanea Life Sciences Inc
  • 10.2.1 Cutanea Life Sciences Inc Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Acne Vulgaris Treatment
  • 10.2.4 Acne Vulgaris Treatment Product Introduction
  • 10.2.5 Cutanea Life Sciences Inc Recent Development
• 10.3 Dermira Inc
  • 10.3.1 Dermira Inc Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Acne Vulgaris Treatment
  • 10.3.4 Acne Vulgaris Treatment Product Introduction
  • 10.3.5 Dermira Inc Recent Development
• 10.4 ELORAC Inc
  • 10.4.1 ELORAC Inc Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Acne Vulgaris Treatment
  • 10.4.4 Acne Vulgaris Treatment Product Introduction
  • 10.4.5 ELORAC Inc Recent Development
• 10.5 Ensol Biosciences Inc
  • 10.5.1 Ensol Biosciences Inc Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Acne Vulgaris Treatment
  • 10.5.4 Acne Vulgaris Treatment Product Introduction
  • 10.5.5 Ensol Biosciences Inc Recent Development
• 10.6 Foamix Pharmaceuticals Ltd
  • 10.6.1 Foamix Pharmaceuticals Ltd Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Acne Vulgaris Treatment
  • 10.6.4 Acne Vulgaris Treatment Product Introduction
  • 10.6.5 Foamix Pharmaceuticals Ltd Recent Development
• 10.7 Galderma SA
  • 10.7.1 Galderma SA Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Acne Vulgaris Treatment
  • 10.7.4 Acne Vulgaris Treatment Product Introduction
  • 10.7.5 Galderma SA Recent Development
• 10.8 GlaxoSmithKline Plc
  • 10.8.1 GlaxoSmithKline Plc Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Acne Vulgaris Treatment
  • 10.8.4 Acne Vulgaris Treatment Product Introduction
  • 10.8.5 GlaxoSmithKline Plc Recent Development
• 10.9 Helix BioMedix Inc
  • 10.9.1 Helix BioMedix Inc Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Acne Vulgaris Treatment
  • 10.9.4 Acne Vulgaris Treatment Product Introduction
  • 10.9.5 Helix BioMedix Inc Recent Development
• 10.10 Hovione FarmaCiencia SA
  • 10.10.1 Hovione FarmaCiencia SA Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Acne Vulgaris Treatment
  • 10.10.4 Acne Vulgaris Treatment Product Introduction
  • 10.10.5 Hovione FarmaCiencia SA Recent Development
• 10.11 Lee's Pharmaceutical Holdings Ltd
• 10.12 LEO Pharma A/S
• 10.13 Novabiotics Ltd
• 10.14 Novan Inc
• 10.15 Novartis AG
• 10.16 Paratek Pharmaceuticals Inc
• 10.17 Pfizer Inc
• 10.18 Phosphagenics Ltd

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Acne Vulgaris Treatment Sales Channels
  • 11.2.2 Acne Vulgaris Treatment Distributors
• 11.3 Acne Vulgaris Treatment Customers

12 Market Forecast

• 12.1 Global Acne Vulgaris Treatment Sales and Revenue Forecast 2019-2025
• 12.2 Global Acne Vulgaris Treatment Sales Forecast by Type
• 12.3 Global Acne Vulgaris Treatment Sales Forecast by Application
• 12.4 Acne Vulgaris Treatment Forecast by Regions
  • 12.4.1 Global Acne Vulgaris Treatment Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Acne Vulgaris Treatment Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

In 2019, the market size of Acne Vulgaris Treatment is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Acne Vulgaris Treatment.

This report studies the global market size of Acne Vulgaris Treatment, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Acne Vulgaris Treatment sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Common Pharma Inc
Cutanea Life Sciences Inc
Dermira Inc
ELORAC Inc
Ensol Biosciences Inc
Foamix Pharmaceuticals Ltd
Galderma SA
GlaxoSmithKline Plc
Helix BioMedix Inc
Hovione FarmaCiencia SA
Lee's Pharmaceutical Holdings Ltd
LEO Pharma A/S
Novabiotics Ltd
Novan Inc
Novartis AG
Paratek Pharmaceuticals Inc
Pfizer Inc
Phosphagenics Ltd

Market Segment by Product Type
CB-0601
CJM-112
CLS-007
Dapsone
DFD-10
DLX-2323
Others

Market Segment by Application
Clinic
Hospital
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Acne Vulgaris Treatment status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Acne Vulgaris Treatment manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Acne Vulgaris Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025